Finance

Lists
ADUS:NASDAQ
Addus Homecare Corporation
$123.00
-0.58%
(-0.72) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADUS...
Open
$123.04
High
$125.74
Low
$122.88
Mkt. cap
2.29B
Avg. vol.
233.45K
Volume
105.10K
P/E ratio
20.49
52-wk high
$131.59
52-wk low
$87.95
EPS
$6.00
Beta
0.75
Shares outstanding
18.63M
No. of employees
28K
Open
$123.04
High
$125.74
Low
$122.88
Mkt. cap
2.29B
Avg. vol.
233.45K
Volume
105.10K
P/E ratio
20.49
52-wk high
$131.59
52-wk low
$87.95
EPS
$6.00
Beta
0.75
Shares outstanding
18.63M
No. of employees
28K
News stories
From web sources and news partners
About Addus Homecare Corporation
CEOR. Dirk Allison
Employees28.3K
Founded1979
HeadquartersFrisco, Texas, United States
SectorHealth Care
IndustryHealth care provider
Websiteaddus.com
Analyst ratings
Based on 8 analysts giving stock ratings to ADUS in the past 3 months
Buy
Buy
5
Hold
2
Sell
1
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ADUS in the last 3 months.
Highest
Current $123.00
$160.00 (+30.08%)
Average
$134.60 (+9.43%)
Lowest
$101.00 (-17.89%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Langston
TD Cowen
Buy
Reiterated
$145.00
+17.9%
11/05/2026
A.J. Rice
UBS
Buy
Reiterated
$160.00
+30.1%
11/05/2026
Sean Dodge
BMO Capital
Hold
Reiterated
$130.00
+5.7%
11/04/2026
Joanna Gajuk
Bank of America Securities
Hold
Maintained
-
-
11/04/2026
Andrew Mok CFA
Barclays
Sell
Maintained
$101.00
-17.9%
11/04/2026
John Ransom
Raymond James
Buy
Reiterated
$137.00
+11.4%
09/28/2026
Clarke Murphy
Truist Financial
Buy
Maintained
-
-
09/15/2026
Jared Haase
William Blair
Buy
Maintained
-
-
09/14/2026
Unknown Analyst
Stephens
Buy
Maintained
$136.00
+10.6%
08/05/2026
Raj Kumar CFA
Stephens
Buy
Maintained
$136.00
+10.6%
08/05/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
$134.00
+8.9%
08/05/2026
Constantine Davides
Citizens JMP
Buy
Maintained
$142.00
+15.4%
05/06/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
-
-
05/07/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
$155.00
+26%
05/06/2026
Jim Salera
Stephens
Buy
Reiterated
$135.00
+9.8%
02/25/2026
Last report
Nov 4, 2026
Fiscal period
Q3 2026
$1.83 / $1.79
+2.11%beat
Revenue / Est. (USD)
387.73M / 388.69M
-0.25%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
373.08M
363.61M
377.42M
387.73M
Cost of goods sold
249.47M
247.74M
258.26M
263.34M
Cost of revenue
249.47M
247.74M
258.26M
263.34M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
77.48M
77.77M
78.49M
80.44M
Operating expense
81.63M
81.80M
82.62M
84.58M
Total operating expenses
331.10M
329.54M
340.88M
347.92M
Operating income
41.98M
34.07M
36.54M
39.82M
Other non operating income
-
-
-
-
EBT including unusual items
40.15M
32.43M
37.78M
39.14M
EBT excluding unusual items
39.85M
32.43M
35.38M
39.14M
Income tax expense
10.37M
7.36M
10.18M
10.55M
Effective tax rate
25.82%
22.70%
26.93%
26.94%
Other operating expenses
-
-
-
-
Net income
29.78M
25.07M
27.61M
28.59M
Net profit margin
7.98%
6.89%
7.31%
7.37%
Earnings per share
1.77
1.62
1.73
1.83
Interest and investment income
597.00K
510.00K
566.00K
586.00K
Interest expense
-2.73M
-2.15M
-1.72M
-1.26M
Net interest expenses
-2.13M
-1.64M
-1.16M
-678.00K
Depreciation and amortization charges
4.15M
4.03M
4.12M
4.14M
EBITDA
46.12M
38.10M
40.67M
43.96M
Gain or loss from assets sale
4.00K
-16.00K
3.00K
-33.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps